T淋巴细胞在食管鳞状细胞癌发生发展过程中的作用

doi:10.3969/j.issn.1006⁃5725.2020.24.029

Abstract

Abstract:

As an important part of cellular immunity，T lymphocytes play a key role in tumor immunotherapy. In the past，chemoradiotherapy and/or surgical treatment had limited effects on overall survival of patients with esophageal squamous cell carcinoma，and immunotherapy that brought survival benefits to tumor patients began to be applied for the treatment of esophageal squamous cell carcinoma. The mechanism of T lymphocytes′ effects on esophageal squamous cell carcinoma has not been fully elucidated yet. Thus exploring the role of T lymphocytes in esophageal squamous cell carcinoma may be helpful for finding new therapeutic approaches. This article reviews the role of T lymphocytes in the development of esophageal squamous cell carcinoma.

Key words:

T lymphocytes, esophageal squamous cell carcinoma, immunotherapy, cellular immunity

WANG Zhizhi, WU Xuan⁃zhen, NI Zhen, HE Yujing, DONG Xiaoying, LIU Xiguang, LU Di, CAI Kaican.

Role of T lymphocytes in progression of esophageal squamous cell carcinoma

[J]. The Journal of Practical Medicine, 2020, 36(24): 3449-3452.

[1]	Xiya MA,Hu JI,Zehua ZHU,Bo PAN,Qiang XIE,Xiaobo. YAO. The predictive value of ¹⁸F⁃FDG PET/CT metabolic heterogeneity parameters combined with clinical features for the prognosis of esophageal squamous cell carcinoma before definitive radiochemotherapy [J]. The Journal of Practical Medicine, 2024, 40(7): 966-971.
[2]	Jiang SHAO,Lin LI,Yansong GUO,Chengyuan SUN,Xichao WEN,Kebin ZHENG,Yanfang SHI. Research progress of CD73/NT5E in glioblastoma [J]. The Journal of Practical Medicine, 2024, 40(3): 428-431.
[3]	Zhaochen SUN,Junyan JIANG,Yitian. CHEN. Advancements in CAR⁃T cell research for the treatment of colorectal cancer [J]. The Journal of Practical Medicine, 2024, 40(18): 2640-2646.
[4]	Ziqi DING,Qian. ZHANG. Research progress in T cell exhaustion and its relationship with respiratory diseases [J]. The Journal of Practical Medicine, 2024, 40(13): 1895-1900.
[5]	Yawei ZHANG,Hongjin SHI,Shi FU,Jiansong WANG,Haifeng WANG. Research progress in biological role of TIGIT and its application in bladder cancer [J]. The Journal of Practical Medicine, 2024, 40(12): 1762-1766.
[6]	Xizhi WEN,Xiaoshi. ZHANG. Immunotherapy based on neoantigen： A personalized treatment strategy for melanoma [J]. The Journal of Practical Medicine, 2024, 40(10): 1331-1337.
[7]	WU Kaiyi, LÜ Xuedong, HE Haiyan, CHEN Jinliang. . Progress in the application of cryoablation combined with immunotherapy in the treatment of NSCLC [J]. The Journal of Practical Medicine, 2023, 39(8): 1058-1062.
[8]	ZHANG Xijie, LI Xin, ZHOU Wence.. Research progress of combined immunotherapy for metastatic pancreas cancer [J]. The Journal of Practical Medicine, 2023, 39(6): 655-659.
[9]	DING Shu, HAN Zhuoying, ZHANG Bowei, YU Weiyong, LUO Chao.. Clinical significance of SLC5A12 expression in esophageal squamous cell carcinoma and its effect on malig⁃ nant phenotype of esophageal squamous cell carcinoma [J]. The Journal of Practical Medicine, 2023, 39(6): 730-737.
[10]	CHEN Fukun, LV Juan, DENG Zhiyong. Effect of chimeric antigen receptor gene⁃modified T⁃cell immunotherapy for lung cancer：A systematic review [J]. The Journal of Practical Medicine, 2023, 39(5): 538-543.
[11]	WU Yang, LU Hanjie, SHUI Huifeng.. The efficacy and safety of anlotinib plus PD⁃1 blockades in patients with advanced non⁃small cell lung can⁃ cer previously treated with immunotherapy [J]. The Journal of Practical Medicine, 2023, 39(5): 572-578.
[12]	Pingping LIN,Fubo LI,Dongjuan WANG,Yan GUO,Yi. DONG. Impacts of circLRP6 on cisplatin resistance to esophageal squamous cell carcinoma by regulating miR⁃125a⁃5p/MCL1 axis [J]. The Journal of Practical Medicine, 2023, 39(17): 2183-2189.
[13]	Xianlan ZHANG,Yufei ZHU,Yunyun ZENG,Zhihao HUANG,Wenchang CEN,Shan. SU. Efficacy and safety of chemotherapy plus immunotherapy and recombinant human endostatin in treating advanced non-small cell lung cancer [J]. The Journal of Practical Medicine, 2023, 39(16): 2112-2115.
[14]	WANG Jing, YANG Yage, ZHENG Xiaoyong, GUO Changqing. . Efficacy and safety of anlotinib monotherapy as the further ⁃ line treatment for patients with advanced esophageal squamous cell carcinoma [J]. The Journal of Practical Medicine, 2022, 38(7): 893-899.
[15]	TIAN Jing, ZHANG Zhiyong, BAI Tiankai, YAN Bin.. CAR ⁃T therapy for pancreatic cancer：Research progress and prospects [J]. The Journal of Practical Medicine, 2022, 38(4): 516-521.

Role of T lymphocytes in progression of esophageal squamous cell carcinoma

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments